According to MarketBeat, analysts’ average target price is $168.69 for Moderna stock, which is 46 percent below its current price. Among the 17 analysts tracking Moderna, eight recommend “buy,” six recommend “hold,” and three recommend “sell.” Their highest target price of $250 is 20 percent below the stock’s current price, while their lowest target of $80 is 74 percent below.
On Jul. 15, Jefferies analyst Michael Yee raised his target price on Moderna stock to $250 from $170 and maintained a “hold” rating. Yee now expects Moderna to generate $21.2 billion in sales in 2021, up from $19.2 billion earlier.
View more information: https://marketrealist.com/p/should-i-sell-moderna-stock/